Loading company…
Riskpilot
← Back to search
Sign in
Get full access
INTEGRA Biosciences Nordic ApS
APS
Active
CVR 43279092
Rugvænget 52C
Wholesale of other machinery and equipment · NACE 4664
Est. 2022
6 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 7,1M
+73% vs 2024
EBITDA margin
10.4%
+157% vs 2024
Equity ratio
-31.2%
Financial strength
Net profit 2025
DKK 414K
+124% vs 2024
EBITDA — year on year
DKK millions
1M
1M
0M
-1M
-1M
-1M
2022
-1M
0%
2023
-1M
0%
2024
1M
+200%
2025
Key figures
Annual report 2025
Revenue
DKK 7,1M
+73%
EBITDA
DKK 738K
+157%
Net profit
DKK 414K
+124%
Total assets
DKK 10,4M
-10%
Equity
DKK -3,2M
+11%
Employees
6
—
Company information
Legal name
INTEGRA Biosciences Nordic ApS
CVR number
43279092
Legal form
Anpartsselskab
NACE code
4664 · Wholesale of other machinery and equipment
Founded
18. maj 2022
Share capital
DKK 40.000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to direktører.
Company purpose
Selskabets formål er at handle med varer, sælge services og dermed forbundet virksomhed.
Contact
Address
Rugvænget 52C
Phone
+4531735373
Email
kirsten.thuesen@integra-biosciences.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of other machinery and equipment
Companies in Høje-Taastrup
All Denmark companies
Revenue
DKK millions
0M
2M
4M
6M
8M
0M
2022
3M
2023
4M
2024
7M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
-1M
2022
-1M
2023
-1M
2024
1M
2025
Income statement
DKK thousands
Item
2022
2023
2024
2025
Revenue
-227
2.905
4.115
7.117
Staff expenses
-773
-3.632
-5.408
-6.379
EBITDA
-1.000
-726
-1.293
738
Depreciation & amort.
-0
-39
-48
-48
EBIT
-1.000
-765
-1.341
689
Net financials
-33
-191
-359
-276
Profit before tax
-1.033
-956
-1.700
414
Tax
-0
-0
-0
-0
Net profit
-1.033
-956
-1.700
414
Balance sheet
DKK thousands
Item
2022
2023
2024
2025
Total assets
2.431
8.624
11.534
10.378
Equity
-993
-1.950
-3.649
-3.236
Long-term debt
0
8.000
8.000
8.000
Short-term debt
3.424
2.574
7.184
5.614
Total debt
3.424
10.574
15.184
13.614
Financial ratios
5-year trend
EBITDA margin
10.4%
This company
15.8%
Market median
-34% vs market
2022
2025
Equity ratio
-31.2%
This company
38.2%
Market median
-182% vs market
2022
2025
Return on equity
41381300.0%
This company
18.4%
Market median
+224898270% vs market
2022
2025
Net profit margin
5.8%
This company
8.1%
Market median
-28% vs market
2022
2025
Asset turnover
0.69×
This company
1.12×
Market median
-38% vs market
2022
2025
Debt / equity
4.21×
This company
0.62×
Market median
-579% vs market
2022
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-05-18 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (3)
SK
Sven Karl Linder
Management
Management
2026
KT
Kirsten Thuesen
Management
Management
2022
TG
Torbjørn Gripp
Management
Management
2022
Former (1)
TS
Thomas Schrofer
Management
Management
2022 – 2026
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
INTEGRA Biosciences Holding AG
Individual
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of INTEGRA Biosciences Nordic ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Sven Karl Linder
Management
0 companies
Kirsten Thuesen
Management
0 companies
Torbjørn Gripp
Management
0 companies
Thomas Schrofer
Management
0 companies